The Effects of Allicor on Patients After Revascularization Treatment During a Year
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT05813171
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT05813171
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT05813171. Randomized; double masking; primary purpose treatment. Start 2023-04-20 (anticipated); primary completion 2024-04-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Allicor on Patients After Revascularization Treatment During a Year
- Acronym
- TEA-PARTY
- Condition
- Atherosclerosis
- Condition
- Peripheral Arterial Disease
- Intervention (Dietary supplement)
- Allicor
- Intervention (Drug)
- Placebo
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
Record details
- Record id
cardio:ct-nct05813171- Content hash
2e14841a89f8b3296b9e72d6dee8d8a7e491bd954b99172c8d683e0bb2cebb73